| Symbol |
Name |
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACKR3
|
atypical chemokine receptor 3
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
|
AKT3
|
v-akt murine thymoma viral oncogene homolog 3
|
|
APOBEC3B
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B
|
|
APOBEC3G
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G
|
|
APOE
|
apolipoprotein E
|
|
AZU1
|
azurocidin 1
|
|
BMX
|
BMX non-receptor tyrosine kinase
|
|
BTK
|
Bruton agammaglobulinemia tyrosine kinase
|
|
CCL1
|
chemokine (C-C motif) ligand 1
|
|
CCL11
|
chemokine (C-C motif) ligand 11
|
|
CCL13
|
chemokine (C-C motif) ligand 13
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL23
|
chemokine (C-C motif) ligand 23
|
|
CCL24
|
chemokine (C-C motif) ligand 24
|
|
CCL26
|
chemokine (C-C motif) ligand 26
|
|
CCL3
|
chemokine (C-C motif) ligand 3
|
|
CCL3L1
|
chemokine (C-C motif) ligand 3-like 1
|
|
CCL4
|
chemokine (C-C motif) ligand 4
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCL7
|
chemokine (C-C motif) ligand 7
|
|
CCL8
|
chemokine (C-C motif) ligand 8
|
|
CCR1
|
chemokine (C-C motif) receptor 1
|
|
CCR2
|
chemokine (C-C motif) receptor 2
|
|
CCR3
|
chemokine (C-C motif) receptor 3
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CCR6
|
chemokine (C-C motif) receptor 6
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
|
CCR9
|
chemokine (C-C motif) receptor 9
|
|
CCRL2
|
chemokine (C-C motif) receptor-like 2
|
|
CD209
|
CD209 molecule
|
|
CDC42
|
cell division cycle 42
|
|
CHUK
|
conserved helix-loop-helix ubiquitous kinase
|
|
CLEC4M
|
C-type lectin domain family 4, member M
|
|
CSK
|
c-src tyrosine kinase
|
|
CTSG
|
cathepsin G
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL11
|
chemokine (C-X-C motif) ligand 11
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL13
|
chemokine (C-X-C motif) ligand 13
|
|
CXCL14
|
chemokine (C-X-C motif) ligand 14
|
|
CXCL2
|
chemokine (C-X-C motif) ligand 2
|
|
CXCL3
|
chemokine (C-X-C motif) ligand 3
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR2
|
chemokine (C-X-C motif) receptor 2
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CXCR6
|
chemokine (C-X-C motif) receptor 6
|
|
CYBB
|
cytochrome b-245, beta polypeptide
|
|
CYP2B6
|
cytochrome P450, family 2, subfamily B, polypeptide 6
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
CYP3A5
|
cytochrome P450, family 3, subfamily A, polypeptide 5
|
|
DEFA4
|
defensin, alpha 4, corticostatin
|
|
DEFB1
|
defensin, beta 1
|
|
DUOX1
|
dual oxidase 1
|
|
DUOX2
|
dual oxidase 2
|
|
DUOXA1
|
dual oxidase maturation factor 1
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
|
FGR
|
FGR proto-oncogene, Src family tyrosine kinase
|
|
FPR1
|
formyl peptide receptor 1
|
|
FYN
|
FYN proto-oncogene, Src family tyrosine kinase
|
|
HCK
|
HCK proto-oncogene, Src family tyrosine kinase
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
|
HLA-DMA
|
major histocompatibility complex, class II, DM alpha
|
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-E
|
major histocompatibility complex, class I, E
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
IFNG
|
interferon, gamma
|
|
IFNL3
|
interferon, lambda 3
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
|
IL10
|
interleukin 10
|
|
IL10RA
|
interleukin 10 receptor, alpha
|
|
IL17C
|
interleukin 17C
|
|
IL18
|
interleukin 18
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
IL2
|
interleukin 2
|
|
IL4
|
interleukin 4
|
|
IL4R
|
interleukin 4 receptor
|
|
IL6
|
interleukin 6
|
|
IRAK1
|
interleukin-1 receptor-associated kinase 1
|
|
IRAK2
|
interleukin-1 receptor-associated kinase 2
|
|
IRAK4
|
interleukin-1 receptor-associated kinase 4
|
|
KARS
|
lysyl-tRNA synthetase
|
|
KIR3DL1
|
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
LCK
|
LCK proto-oncogene, Src family tyrosine kinase
|
|
LYN
|
LYN proto-oncogene, Src family tyrosine kinase
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK10
|
mitogen-activated protein kinase 10
|
|
MAPK11
|
mitogen-activated protein kinase 11
|
|
MAPK13
|
mitogen-activated protein kinase 13
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPK9
|
mitogen-activated protein kinase 9
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
NCF2
|
neutrophil cytosolic factor 2
|
|
NCF4
|
neutrophil cytosolic factor 4, 40kDa
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NFKBIB
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta
|
|
NFKBIE
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon
|
|
NOS1
|
nitric oxide synthase 1 (neuronal)
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOX1
|
NADPH oxidase 1
|
|
NOX3
|
NADPH oxidase 3
|
|
NOX4
|
NADPH oxidase 4
|
|
NOX5
|
NADPH oxidase, EF-hand calcium binding domain 5
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
P2RY1
|
purinergic receptor P2Y, G-protein coupled, 1
|
|
P2RY2
|
purinergic receptor P2Y, G-protein coupled, 2
|
|
PAK1
|
p21 protein (Cdc42/Rac)-activated kinase 1
|
|
PAK2
|
p21 protein (Cdc42/Rac)-activated kinase 2
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
|
|
PIK3CD
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PIK3R1
|
phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
|
|
PIK3R5
|
phosphoinositide-3-kinase, regulatory subunit 5
|
|
PLA2G2A
|
phospholipase A2, group IIA (platelets, synovial fluid)
|
|
PLA2G2D
|
phospholipase A2, group IID
|
|
PLA2G2E
|
phospholipase A2, group IIE
|
|
PLA2G2F
|
phospholipase A2, group IIF
|
|
PLA2G3
|
phospholipase A2, group III
|
|
PLA2G4A
|
phospholipase A2, group IVA (cytosolic, calcium-dependent)
|
|
PLA2G4B
|
phospholipase A2, group IVB (cytosolic)
|
|
PLA2G4C
|
phospholipase A2, group IVC (cytosolic, calcium-independent)
|
|
PLCB1
|
phospholipase C, beta 1 (phosphoinositide-specific)
|
|
PLCB2
|
phospholipase C, beta 2
|
|
PLCB3
|
phospholipase C, beta 3 (phosphatidylinositol-specific)
|
|
PLCB4
|
phospholipase C, beta 4
|
|
PLCD1
|
phospholipase C, delta 1
|
|
PLCD3
|
phospholipase C, delta 3
|
|
PLCD4
|
phospholipase C, delta 4
|
|
PLCE1
|
phospholipase C, epsilon 1
|
|
PLCG1
|
phospholipase C, gamma 1
|
|
PLCG2
|
phospholipase C, gamma 2 (phosphatidylinositol-specific)
|
|
POSTN
|
periostin, osteoblast specific factor
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTK2B
|
protein tyrosine kinase 2 beta
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAC2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2)
|
|
RHOA
|
ras homolog family member A
|
|
RHOC
|
ras homolog family member C
|
|
RHOG
|
ras homolog family member G
|
|
ROCK1
|
Rho-associated, coiled-coil containing protein kinase 1
|
|
ROCK2
|
Rho-associated, coiled-coil containing protein kinase 2
|
|
SDCCAG8
|
serologically defined colon cancer antigen 8
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
|
SLAIN2
|
SLAIN motif family, member 2
|
|
SLC26A4
|
solute carrier family 26 (anion exchanger), member 4
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
TAP2
|
transporter 2, ATP-binding cassette, sub-family B (MDR/TAP)
|
|
TEC
|
tec protein tyrosine kinase
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TLR2
|
toll-like receptor 2
|
|
TLR3
|
toll-like receptor 3
|
|
TLR4
|
toll-like receptor 4
|
|
TLR5
|
toll-like receptor 5
|
|
TLR7
|
toll-like receptor 7
|
|
TLR8
|
toll-like receptor 8
|
|
TLR9
|
toll-like receptor 9
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TRAF1
|
TNF receptor-associated factor 1
|
|
TRAF2
|
TNF receptor-associated factor 2
|
|
TRAF3
|
TNF receptor-associated factor 3
|
|
TRAF4
|
TNF receptor-associated factor 4
|
|
TRAF5
|
TNF receptor-associated factor 5
|
|
TRAF6
|
TNF receptor-associated factor 6, E3 ubiquitin protein ligase
|
|
UGT1A1
|
UDP glucuronosyltransferase 1 family, polypeptide A1
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
YES1
|
YES proto-oncogene 1, Src family tyrosine kinase
|
|
ZAP70
|
zeta-chain (TCR) associated protein kinase 70kDa
|
